Case Reports in Oncological Medicine

Editorial Board

Academic Editors

  • Fadi F. Attiyeh, Columbia University, USA
  • Jeanine M. Buchanich , University of Pittsburgh, USA
  • Marinela Capanu, Memorial Sloan-Kettering Cancer Center, USA
  • James CS Chim, University of Hong Kong, Hong Kong
  • Mauro Cives , University of Bari 'Aldo Moro', Italy
  • Guido Fadda, Catholic University - Rome, Italy
  • Constantine Gennatas, University of Athens, Greece
  • Jun Itami, National Cancer Center Hospital, Japan
  • Kaiser Jamil, Bhagwan Mahavir Medical Research Centre, India
  • Yu-Fei Jiao, Harbin Medical University, China
  • Peter F. Lenehan, Everist Genomics, USA
  • David Lindquist, Umeå University, Sweden
  • Francesco A. Mauri, Imperial College London, United Kingdom
  • Jose I. Mayordomo, Universidad de Zaragoza, Spain
  • Raffaele Palmirotta , University of Bari 'Aldo Moro', Italy
  • Josep M. Ribera, Universidad Autónoma de Barcelona, Spain
  • Giovanni Tallini, University of Bologna, Italy
  • Su Ming Tan , Changi General Hospital, Singapore
  • Katsuhiro Tanaka , Kawasaki Medical School, Japan
  • Ossama W. Tawfik , MAWD Pathology Group, USA
  • Xavier G. Thomas, Centre Hospitalier Lyon-Sud, France
  • Ming-Hsui Tsai, China Medical University Hospital, Taiwan
  • Huamin Wang, The University of Texas M. D. Anderson Cancer Center, USA
  • Yoshihito Yokoyama , Hirosaki University, Japan
    Case Reports in Oncological Medicine
     Journal metrics
    Acceptance rate43%
    Submission to final decision121 days
    Acceptance to publication19 days
    Impact Factor-

    We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.